Obesity Drug Safety Debate Escalates in Medical Journal Obesity Drug Safety Debate Escalates in Medical Journal
Arguments and accusations fly as physicians and others debate the FDA's wisdom in approving lorcaserin and phentermine-topiramate. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Adipex | Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | Obesity | Phentermine | Topamax